Cradle-to-gate life cycle inventory of Vancomycin hydrochloride (cas 1404-93-9)

Add time:09/06/2019    Source:sciencedirect.com

A life cycle analysis on the cradle-to-gate production of vancomycin hydrochloride, which begins at natural resource extraction and spans through factory (gate) production, not only shows all inputs, outputs, and energy usage to manufacture the product and all related supply chain chemicals, but can highlight where process changes would have the greatest impact on raw material and energy consumption and emissions. Vancomycin hydrochloride is produced by a low-yield fermentation process that accounts for 47% of the total cradle-to-gate energy. The fermentation step consumes the most raw materials and energy cradle-to-gate. Over 75% of the total cradle-to-gate energy consumption is due to steam use; sterilization within fermentation is the largest user of steam. Aeration and agitation in the fermentation vessels use 65% of the cradle-to-gate electrical energy. To reduce raw materials, energy consumption, and the associated environmental footprint of producing vancomycin hydrochloride, other sterilization methods, fermentation media, nutrient sources, or synthetic manufacture should be investigated. The reported vancomycin hydrochloride life cycle inventory is a part of a larger life cycle study of the environmental consequences of the introduction of biocide-coated medical textiles for the prevention of MRSA (methicillin-resistant Staphylococcus aureus) nosocomial infections.

We also recommend Trading Suppliers and Manufacturers of Vancomycin hydrochloride (cas 1404-93-9). Pls Click Website Link as below: cas 1404-93-9 suppliers

Prev:Residual amount of Vancomycin hydrochloride (cas 1404-93-9) in vials after use
Next:Controlled release of Vancomycin hydrochloride (cas 1404-93-9) from a composite structure of polymeric films and porous fibers on implants)